← Leaderboards
Wohaib Hasan
Oregon Health & Science University
$1,736,000
Attributed
$1,736,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $437.5K · FY2011–20$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,736,000 · 2
By mechanism
R01$1,312,500 · 1
R21$423,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Owen J McCarty$13,437,961
- Monica T Hinds$9,084,363
- Zhenying Nie$2,606,776
- Melinda D Wu$1,113,097
- Rick Mathews$212,958
Others in their field
Top investigators on “Plasma”
- David Heimbrook · Leidos Biomedical Research, Inc.$170,532,526
- Barton F Haynes · Duke University$119,611,088
- Paul S. Aisen · Cognition Therapeutics, Inc.$110,079,727
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$93,527,289
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$85,429,770
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$78,577,996
Research focus
PlasmaCongestive Heart FailureNerveToxic EffectNeuronsGalaninHeartIn VivoNeuropeptide YProteinsCatecholaminesNeuropeptidesHeart RateCardiacBlood Coagulation FactorBlood Coagulation DisordersAnticoagulant TherapyBaseAutonomic NerveAnticoagulantsAdrenergicCell Culture TechniquesCell LineAttenuation
Grant awards (5)
Neuropeptides reduce thrombosis risk in heart failure$437,500
R01 · FY2020 · HL · contact PI
Neuropeptides reduce thrombosis risk in heart failure$437,500
R01 · FY2019 · HL · contact PI
Neuropeptides reduce thrombosis risk in heart failure$437,500
R01 · FY2018 · HL · contact PI
Attenuation of cardiac parasympathetic nerve acetylcholine release in obesity by$192,500
R21 · FY2012 · NS · contact PI
Attenuation of cardiac parasympathetic nerve acetylcholine release in obesity by$231,000
R21 · FY2011 · NS · contact PI